CytoTherapeutics, StemCells deal

CTII will acquire StemCells for $7.9 million in CTII stock. CTII said the acquisition

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE